XML 20 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Balance, beginning of year (in shares) at Nov. 30, 2017 [1]     47,281,000          
Balance, beginning of year at Nov. 30, 2017 $ 404,381 [1] $ 0 $ 473 [1] $ 249,363 [1] $ 641 $ 172,951 [1] $ (641) $ (18,406) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of stock under employee stock purchase plan (in shares)     225,000          
Issuance of stock under employee stock purchase plan 5,458   $ 2 5,456        
Exercise of stock options (in shares)     189,000          
Exercise of stock options 3,858   $ 2 3,856        
Vesting of restricted stock units and release of deferred stock units (in shares)     407,000          
Vesting of restricted stock units and release of deferred stock units 4   $ 4          
Withholding tax payments related to net issuance of restricted stock units (in shares)     (108,000)          
Withholding tax payments related to net issuance of restricted stock units (3,999)   $ (1) (3,998)        
Stock-based compensation 20,569     20,569        
Dividends declared $ (26,169)         (26,169)    
Treasury stock repurchases and retirements (in shares) (2,900,000)   (2,879,000)          
Treasury stock repurchases and retirements $ (120,000)   $ (29) (9,285)   (110,686)    
Net income 49,670 [2],[3]         49,670    
Other comprehensive income (loss), net of tax (9,770) [4]             (9,770)
Balance, end of year (in shares) at Nov. 30, 2018 [1]     45,115,000          
Balance, end of year at Nov. 30, 2018 324,002 [1] $ 4,781 $ 451 [1] 266,602 [1]   85,125 [1] $ 4,781 (28,176) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of stock under employee stock purchase plan (in shares)     189,000          
Issuance of stock under employee stock purchase plan 5,507   $ 2 5,505        
Exercise of stock options (in shares)     119,000          
Exercise of stock options 3,621   $ 1 3,620        
Vesting of restricted stock units and release of deferred stock units (in shares)     364,000          
Vesting of restricted stock units and release of deferred stock units 3   $ 4 (1)        
Withholding tax payments related to net issuance of restricted stock units (in shares)     (106,000)          
Withholding tax payments related to net issuance of restricted stock units (4,278)   $ (1) (4,277)        
Stock-based compensation 23,311     23,311        
Issuance of shares related to non-compete agreement (in shares)     44,000          
Issuance of shares related to non-compete agreement 2,000     2,000        
Dividends declared $ (28,267)         (28,267)    
Treasury stock repurchases and retirements (in shares) (700,000)   (688,000)          
Treasury stock repurchases and retirements $ (25,000)   $ (7) (1,257)   (23,736)    
Net income 26,400         26,400    
Other comprehensive income (loss), net of tax $ (1,798)             (1,798)
Balance, end of year (in shares) at Nov. 30, 2019 45,036,441   45,037,000          
Balance, end of year at Nov. 30, 2019 $ 330,282   $ 450 295,503   64,303   (29,974)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of stock under employee stock purchase plan (in shares)     237,000          
Issuance of stock under employee stock purchase plan $ 6,606   $ 2 6,604        
Exercise of stock options (in shares) 137,000   137,000          
Exercise of stock options $ 4,361   $ 1 4,360        
Vesting of restricted stock units and release of deferred stock units (in shares)     416,000          
Vesting of restricted stock units and release of deferred stock units 0   $ 4 (4)        
Withholding tax payments related to net issuance of restricted stock units (in shares)     (140,000)          
Withholding tax payments related to net issuance of restricted stock units (5,331)   $ (1) (5,330)        
Stock-based compensation 23,482     23,482        
Dividends declared $ (30,305)         (30,305)    
Treasury stock repurchases and retirements (in shares) (1,400,000)   (1,446,000)          
Treasury stock repurchases and retirements $ (60,000)   $ (14) (18,813)   (41,173)    
Net income 79,722         79,722    
Other comprehensive income (loss), net of tax $ (2,804)             (2,804)
Balance, end of year (in shares) at Nov. 30, 2020 44,240,635   44,241,000          
Balance, end of year at Nov. 30, 2020 $ 346,013   $ 442 $ 305,802   $ 72,547   $ (32,778)
[1] (1)The Company adopted the accounting standard related to revenue recognition ("ASC 606") effective December 1, 2018 using the full retrospective method. See Note 1. Nature of Business and Summary of Significant Accounting Policies for further information.
[2] (1)The Company adopted the accounting standard related to revenue recognition ("ASC 606") effective December 1, 2018 using the full retrospective method. See Note 1. Nature of Business and Summary of Significant Accounting Policies for further information.
[3] (1)The Company adopted the accounting standard related to revenue recognition ("ASC 606") effective December 1, 2018 using the full retrospective method. See Note 1. Nature of Business and Summary of Significant Accounting Policies for further information.
[4] (1)The Company adopted the accounting standard related to revenue recognition ("ASC 606") effective December 1, 2018 using the full retrospective method. See Note 1. Nature of Business and Summary of Significant Accounting Policies for further information.